BIBLIOGRAPHY

 Peer Reviewed Articles  

1. Pourshoghi A, Danesh A, Tabby DS, Grothusen J, Pourrezaei K; Cerebral reactivity in migraine patients measured with functional near-infrared spectroscopy; Eur J Med Res. 2015 Dec 8;20:96 
2. Libon, David J; Penney, Dana L; Davis, Randal; Tabby, David S; Deficits in processing speed and decision making in relapsing-remitting multiple sclerosis: The Digit Clock Drawing Test; Journal of Multiple Sclerosis; 1; 113; 2; 2014; Sage
3. Tabby D Headache in Multiple Sclerosis POMA Journal, December 2014
4. Holland N, Panchani M, Tabby D, Cheng J Using test scores to optimize neurology e -learning. Medical Education World
5. Holland NR, Grinberg I, Tabby D. A standardized online clinical education and assessment tool for neurology clerkship students assigned to multiple sites. Perspect Med Educ. 2014 Jan;3(1):41-5
6. Confavreux C for the TOWER Trial Group Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomized, double-blind, placebo-controlled, phase 3 trial.  Lancet Neurol. 2014 Jan 22. pii: S1474-4422(13)70308-9. (contributor)
7. J Wilcox, D Tabby, MH Majeed, B Youngman Headache in Multiple Sclerosis: Features and Implications for Disease Management (P6. 163) Neurology 82 (10 Supplement) April 9, 2014
8. Tabby, DS; Majeed, M; Youngman, B; Wilcox, J. Headache in Multiple Sclerosis: Features and Implications for Disease Management  Int J MS Care 2013;15:73–80.
9. Cohen JA, Coles AJ, Arnold DL, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj G, Tabby D (collaborator) CARE-MS I investigators. Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomized controlled phase 3 trial.. Lancet 2012 11/24;380(9856):1819-28. 
10. Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP,Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela Tabby D (collaborator) CARE-MS II      investigators. Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial. Lancet. 2012Nov 24;380(9856):1829-39. 
11. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Tabby D (collaborator) Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012 Dec 20;367(25):2375-84.
12. Choi, R, Tabby, DS,      Schwartzman, RJ. Neurology Resident Conferences: Should Students Attend Morning Report and Grand Rounds?  Annals of Behavioral Science and Medical Education, June 2012. 
13. Stoll S, Nieves C, Tabby DS, Use of therapies other than disease-modifying agents, including complementary and alternative medicine, by patients with multiple sclerosis: a survey study. JAOA, 2012, 112:1 
14. Tabby DS, Majeed MH, Schwartzman RJ. Problem neurology residents: a national survey. Neurology. 2011 Jun 14;76(24):2119-23.
15. Choi RK, Tabby DS, Rosso AL, Mueller PS, Schwartzman RJ, Current status of neurology grand rounds. Neurologist. 2010 Sep;16(5):308-12.
16. Tan H, Yu J, Tabby D, Devries A, Singer J. Clinical and economic impact of a specialty care management program among patients with multiple sclerosis: a cohort study.  Mult Scler. 2010 Aug;16(8):956-63. 
17. Peterlin BL, Alexander G, Tabby D, Reichenberger E.Oligomerization state-dependent elevations of Adiponectin in chronic daily headache. Neurology. 2008 May 13;70(20):1905-1
18. Schlossberg D, Alam M, Morganstern N, Tabby DS, Tabes Dorsalis: Dramatic Improvement with      Penicillin Therapy Tabes Dorsalis: Dramatic Improvement with Penicillin Therapy Infectious Disease in Clinical Practice 1998;7:244-6
19. Tabby DS, Schwartzman RJ Reflex Sympathetic Dystrophy: A Review of 200 cases Journal of the American College of Neuropsychiatrists, Feb/Mar 1989, p.20- 24.

Book chapter 

Neurology and Psychiatry chapter co-editor, Review of Internal Medicine, for Kelley's Textbook of Internal Medicine, David Schlossberg, ed., Lippincott-Raven, Phila, PA. 3rd and 4th editions

Posters

1. Headache in Multiple Sclerosis: Features and Implications for Disease Management Wilcox J; Tabby D, American Academy of Neurology, Phila., PA, 2014 

2. Non-Invasive Blood Flow Monitoring with fNIR: Self-Assessment in Subjects Receiving Infusions for Chronic Migraine Tabby D; Danesh A; American Academy of Neurology Phila., PA, 2012

3. Diagnostic Accuracy of the BESTest to Assess Balance in Ambulatory Persons with Multiple Sclerosis Mitchell KD; Tabby D; Chen Am Physical Therapy Association San Diego, CA 2013 

4. Letter Fluency Testing of Multiple Sclerosis Patients: Performance declines over brief time epochs Tabby D; Eppig J; Tart-Zelvin A; ECTRIMS, Lyon, France, 2013

5. EDSS and Performance on Tests of Visuoconstruction, Working Memory, and Processing Speed in Multiple Sclerosis Tabby D; Eppig J, D Am Academy of Neurology, New Orleans, LA, 2012

6. A Process Approach to Letter Fluency Performance in Multiple Sclerosis Evidence for Derailed Temporal Gradients Tart-Zelvin Tabby D.  Am Acad Neuropsychology Seattle, WA, 2012

7. Clock Drawing in Multiple Sclerosis: Relationship with Executive Functioning and Episodic Memory Eppig J; Nieves; C Xu, A; Tabby D; Libon D Intl Soc Neuroscience, New Orleans, LA, 2010

8. What Is the Effect of Logging Abnormal Clinical Signs on Medical Student Knowledge Acquisition during the Neurology Clerkship Tabby D Am Academy of Neurology, Toronto, ON, 2010

9. Clinical & economic impact of a specialty care management program among patients with MS Tan H; Yu J; Tabby D; Singer J. Consortium of MS Centers Atlanta, GA, 2009

10. Neurological Grand Rounds: Current State of Affairs, Tabby D, Choi R, Rosso A, Mueller, P and Schwartzman, R; American Acad of Neurology, Seattle, WA, 2009

11. Oligomerization State-Dependent Elevations of the Adipocytokine, Adiponectin Chronic Daily Headache Peterlin, B, Alexander, W, Tabby D American Acad of Neurology, Chicago, IL, 2009

12. Reflex Sympathetic Dystrophy: Exploring Sympathetic Function Benninghoff, MG, DeJoseph M, Greene C, Tabby D American Osteopathic Association, San Antonio, TX, 1997

13. Neuropsychological Distinctions between Vascular & Alzheimer's Dementia Zwil S, Gibson W, Nardozzi L Tabby D American Psychological Association, Washington, D.C., 1993

MEDIA APPEARANCES

● MS Discovery Forum podcast “MS and balance-based torso weighting” August 2105

● MS Discovery Forum podcast “MS and headache” July 2015

● WMMR-FM Philadelphia “What is MS and how is it treated?”  Sept 2013

● KYW-News Radio 1060 “Multiple Sclerosis” aired over AM rush hour March 2011

● DUCOM podcast “Multiple Sclerosis”   January 2009